2‐Methoxyestradiol modulates β‐catenin in prostate cancer cells: A possible mediator of 2‐methoxyestradiol‐induced inhibition of cell growth

Abstract

2-Methoxyestradiol (2-ME 2 ) is a novel anticancer agent because of its ability to potentiate apoptotic cell death and inhibit cancer cell growth and angiogenesis. The modes of action of this agent, however, have not yet been fully elucidated. In our study, we have investigated whether 2-ME2 is able to modulate b-catenin signaling in prostate cancer cells, which is one of the major players in cell-cell adhesion, proliferation, apoptosis and carcinogenesis. We found that b-catenin levels were significantly upregulated by 2-ME 2 in a dose-dependent manner in androgen dependent and independent prostate cancer total cellular extracts. We further show that b-catenin levels were significantly increased in the membrane fraction, while nuclear fractions of b-catenin were downregulated in the 2-ME 2 -treated cells. Accumulation of dephospho-b-catenin (nondegraded form) parallel with Bcl-2 and Cyclin D1 downregulation was also achieved after 2-ME 2 treatment. Moreover, we demonstrate that the b-catenin production by 2-ME 2 is mediated through the MEK/ERK-2 signaling pathway. Collectively, these results suggest that the cytostatic effect of 2-ME 2 may be mediated through the prevention of the translocation of b-catenin to the nucleus parallel with an increase in cell-cell adhesion by increasing membrane b-catenin production, eventually preventing cell migration. Moreover, dephospho-b-catenin accumulation by 2ME 2 in the cytoplasm may contribute to the induction of apoptosis of these cells. Finally, studies testing the efficacy of 2-ME 2 in human prostate cancer are warranted to determine whether the inhibition of the expected loss of membranous b-catenin and the upregulation of nuclear b-catenin can prevent prostate cancer development and progression. ' 2007 Wiley-Liss, Inc.

Chemoprevention of intestinal adenomatous polyposis by acetyl‐11‐keto‐beta‐boswellic acid in APCMin/+ mice

“…26 However, β‐catenin is a dynamic protein that, under pathological condition of the Wnt signaling cascade, enters the nucleus and binds with TCF/LEF‐1 proteins, resulting in the transactivation of many target genes associated with the intestinal adenomatous proliferation. This dysregulation of β‐catenin has been associated with the development of tumorigenesis 27. Therefore, β‐catenin is considered to be a pivotal activator for the formation and expansion of intestinal adenomas 28, 29.…”

Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells

“…2-methoxyestradiol induces β-catenin expression in prostate cancer cells, but blocks β-catenin degradation, as well as its cytoplasmic or nuclear accumulation, resulting in cell cycle arrest and apoptosis [29]. Therefore, we performed immunofluorescent staining to analyze the changes in the subcellular localization of β-catenin and E-cadherin induced by claudin-1 knockdown or tamoxifen treatment.…”

Hydroxyestrogens inhibit angiogenesis in swine ovarian follicles

“…Estradiol metabolism generates hormones with distinct biologic activity (Grow 2002); in particular, it is aromatically hydroxylated by the cytochrome 1A1 and 1B1 group of enzymes to produce hydroxyestrogens, which have been demonstrated to act as anti-estrogens in several estrogen-dependent systems such as the breast (Raju et al 2000) and uterus . There is now convincing evidence that the natural estrogen metabolite 2-methoxyestradiol is able to inhibit angiogenesis in several organs such as the ovaries, stomach, and prostate (Basini et al 2007b, Lin et al 2007, Van Veldhuizen et al 2008. Other anti-angiogenic factors at ovarian level are represented by progesterone (Jaggers et al 1996), prostaglandins (Girsh et al 1995), and metalloproteases, since the principal step in angiogenesis is degradation of the basement membrane (Auerbach & Auerbach 1994).…”